https://www.selleckchem.com/pr....oducts/fasoracetam-n
One of the risk factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is postulated to be vitamin D deficiency. To understand better the role of vitamin D deficiency in the disease course of COVID-19, we undertook a retrospective case-control study in the North West of England (NWE). To examine whether hospitalisation with COVID-19 is more prevalent in individuals with lower vitamin D levels. The study included individuals with results of serum 25-hydroxyvitamin D (25[OH]D) between 1 st April 2020